Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Depression News

News
Depression Associated With a 51% Higher Risk of Dementia
11/03/2022
Evi Arthur
Proactive treatment can help to mitigate chance of dementia.
Proactive treatment can help to mitigate chance of dementia.
Proactive treatment can help to...
11/03/2022
Psych Congress Network
From DepressionCare360
Tackling Depression With Psychedelic-Assisted Therapies
11/02/2022
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
Andrew Penn, MS, PMHNP, explains...
11/02/2022
Psych Congress Network

Advertisement

News
Ketamine Reduces Suicidal Ideation in Treatment-Resistant Patients
10/31/2022
Evi Arthur
Ketamine was found to be an effective treatment for patients with treatment-resistant depression.
Ketamine was found to be an effective treatment for patients with treatment-resistant depression.
Ketamine was found to be an...
10/31/2022
Psych Congress Network
News
Depression Risk Rises With More Hours Worked, Study of US First-Year Physicians Finds
10/28/2022
Brionna Mendoza
The more hours a first-year medical resident worked in a week, the higher their chances of developing depressive symptoms rose, according to study results published in the New England Journal of Medicine.
The more hours a first-year medical resident worked in a week, the higher their chances of developing depressive symptoms rose, according to study results published in the New England Journal of Medicine.
The more hours a first-year...
10/28/2022
Psych Congress Network
News
Study Finds Rise in Major Depressive Episodes, but Not Treatment, in Older Adults
10/19/2022
Jolynn Tumolo
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a...
10/19/2022
Psych Congress Network

Advertisement

From DepressionCare360
Adjunctive D-Cycloserine Improves Efficacy of Brain Stimulation in Patients with MDD
10/17/2022
Adding D-cycloserine to intermittent TBS significantly improved outcomes in patients with MDD.
Adding D-cycloserine to intermittent TBS significantly improved outcomes in patients with MDD.
Adding D-cycloserine to...
10/17/2022
Psych Congress Network
News
Neuropsychiatric Polygenic Risk Scores Associated With Psychiatric Diagnoses in Veterans
10/05/2022
Jolynn Tumolo
Polygenic risk scores for schizophrenia, bipolar disorder, and major depression were associated with receiving psychiatric diagnoses and were higher among patients with more hospitalizations, according to a study published in JAMA Psychiatry.
Polygenic risk scores for schizophrenia, bipolar disorder, and major depression were associated with receiving psychiatric diagnoses and were higher among patients with more hospitalizations, according to a study published in JAMA Psychiatry.
Polygenic risk scores for...
10/05/2022
Psych Congress Network
News
Zuranolone Eases MDD for Majority of Study Participants, Interim Analysis Shows
09/18/2022
Jolynn Tumolo
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase...
09/18/2022
Psych Congress Network

Advertisement

News
Postpartum Depression Ameliorated by Lay Health Professional Visits at Home
09/01/2022
Brionna Mendoza
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression...
09/01/2022
Psych Congress Network
News
At-Home, Sublingual Ketamine Therapy Rapidly Improves Anxiety, Depressive Symptoms
08/02/2022
Jolynn Tumolo
Sublingual, at-home ketamine-assisted therapy over 4 weeks was safe and effective for patients with moderate to severe anxiety and depression in what is thought to be the largest study to date of any type of ketamine treatment.
Sublingual, at-home ketamine-assisted therapy over 4 weeks was safe and effective for patients with moderate to severe anxiety and depression in what is thought to be the largest study to date of any type of ketamine treatment.
Sublingual, at-home...
08/02/2022
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use